Screener
Disc Medicine IRON EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Disc Medicine in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Disc Medicine’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 8:33 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-205192
FAQ
- What is Disc Medicine's EPS (diluted)?
- Disc Medicine (IRON) reported EPS (diluted) of -$1.65 in Q1 2026.
- How has Disc Medicine's EPS (diluted) changed year-over-year?
- Disc Medicine's EPS (diluted) decreased by 61.8% year-over-year, from -$1.02 to -$1.65.
- What is the long-term trend for Disc Medicine's EPS (diluted)?
- Over 4 years (2021 to 2025), Disc Medicine's EPS (diluted) has grown at a -38.2% compound annual growth rate (CAGR), from -$40.98 to -$5.99.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Disc Medicine's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude